← All indications
Kidney Calculi
Stones in the KIDNEY, usually formed in the urine-collecting area of the kidney (KIDNEY PELVIS). Their sizes vary and most contains CALCIUM OXALATE.
Subtype terms (1)
More specific conditions that are subtypes of Kidney Calculi in the MeSH hierarchy.
- Staghorn Calculi
1 drug approved
Drugs by status
Phase 4 trials (29)
- hydrocodone
- sodium citrate
- allopurinol
- vitamin e
- mirabegron
- chlorthalidone
- oxycodone
- ibuprofen
- erythritol
- ketorolac
- naftopil
- vitamin c
- ropivacaine
- acetaminophen
- potassium citrate
- sulfamethoxazole
- tramadol
- verapamil
- ciprofloxacin
- losartan
- sodium bicarbonate
- nitrofurantoin
- sodium chloride
- trimethoprim
- vitamin a
- remifentanil
- dexamethasone
- selenium
- magnesium citrate
Phase 3 trials (18)
Phase 2 trials (11)
Phase 1 trials (4)
Organizations
Organization Involved with Phase 4 Indications (38)
- Grunenthal
- Dong-A Pharmaceutical
- Ouiheng International Healthcare Co., Ltd
- University of Roma La Sapienza
- Club des Jeunes Néphrologues
- Chulalongkorn University
- Dartmouth University
- Duke University
- University of Washington
- Indiana University
- Mansoura University
- McMaster University
- New York University
- Ohio State University
- Siriraj Hospital
- University of Iowa
- University of Rochester
- Wake Forest University
- Mayo Clinic
- Prince of Songkla University
- University of British Columbia
- University of California, Irvine
- University of California, San Diego
- University of Copenhagen
- Vanderbilt University
- Hebrew University
- University of Sao Paulo
- Chiangmai University
- University of Wisconsin
- University of Sherbrooke
- +8 more
Organization Involved with Phase 3 Indications (18)
- National Center for Research Resources (NCRR)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- United States Navy
- Centre Hospitalier Departemental Vendee
- Harvard University
- Northwell Health
- University of Toronto
- University of Bern
- Aalborg University
- University of Missouri
- University of Lyon
- Free University of Brussels
- Hospital Little Belt, Fredericia
- Fredericia & Kolding Hospitals
- University of Paris
- Fredericia Hospital
- Canadian Urological Association
- Yeshiva University
Organization Involved with Phase 2 Indications (15)
- Mission Pharmacal
- Takeda
- Allena Pharmaceuticals
- Omeros Corporation
- Amai Charitable Trust
- National Institutes of Health (NIH)
- National Center for Complementary and Integrative Health (NCCIH)
- University of Kansas
- University of Tehran
- Yale University
- Sultan Qaboos University
- Tel Aviv University
- Watson Pharmaceuticals
- University of North Carolina at Chapel Hill
- Himalaya Herbal Healthcare
Organization Involved with Phase 1 Indications (1)
Organization Involved with Other Experimental Indications (18)
- Sanofi
- United States Army
- Cairo University
- Emory University
- Guangzhou Medical University
- Medical University of Warsaw
- Queen's University, Belfast
- Shifa International Hospital
- Tufts University
- University of Chicago
- WellSpan Health
- Kafrelsheikh University
- Princess Anna Mazowiecka Hospital
- Government of Mexico
- National Autonomous University of Mexico
- University of Alabama, Birmingham
- Department of Veteran Affairs
- University Clermont Auvergne